The Medical Letter on Drugs and Therapeutics
Correction: Secondary Prevention of Stroke
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

In the article on Secondary Prevention of Stroke in the December 8, 2014 issue of The Medical Letter (volume 56, page 125), the duration of treatment with clopidogrel plus aspirin in patients who have had a stroke or TIA should be limited to 21 days, not 90 days. This error, which appears twice, in the paragraphs titled "Clopidogrel Plus Aspirin" and "Conclusion", has been corrected in the article as it ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Correction: Secondary Prevention of Stroke
Article code: 1463e
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian